GHK-Cu vs Sermorelin
A comprehensive, data-driven comparison of GHK-Cu (Copper Peptide) and Sermorelin (GHRH 1-29). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | GHK-Cu Copper Peptide, GHK-Copper | Sermorelin GHRH 1-29, GRF 1-29 |
|---|---|---|
| FDA Status | Not submitted | Withdrawn (off-label use continues) |
| Category | Anti-Aging | Growth Hormone |
| Primary Use | Skin rejuvenation and anti-aging | Growth hormone deficiency and anti-aging |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $150/mo | $150 - $350/mo |
| Administration | Topical | Subcutaneous injection |
| Typical Dose | 1-2% topical cream daily, or 1-2mg injection | 200-500mcg daily before bed |
| Frequency | Daily | Daily |
| Mechanism | Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and has antioxidant properties | Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH production |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Moderate |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1GHK-Cu is generally more affordable ($30 - $150/mo) compared to Sermorelin ($150 - $350/mo).
- 2GHK-Cu is administered via topical, while Sermorelin uses subcutaneous injection.
- 3They belong to different categories: GHK-Cu (Anti-Aging) vs Sermorelin (Growth Hormone).
Which Is Better For...
GHK-Cu
More budget-friendly option with lower monthly costs
GHK-Cu
Fewer commonly reported side effects
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| GHK-Cu | $30 - $150/mo | Not submitted | Various research labs |
| Sermorelin | $150 - $350/mo | Withdrawn (off-label use continues) | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
GHK-Cu works via Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and. Sermorelin works via Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH. They differ in FDA approval status, efficacy data, and cost.
GHK-Cu typically costs $30 - $150/mo, while Sermorelin costs $150 - $350/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
GHK-Cu is not FDA-approved (Not submitted). Sermorelin is not FDA-approved (Withdrawn (off-label use continues)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of GHK-Cu include Mild skin irritation (topical), Injection site reactions, Temporary copper taste. Common side effects of Sermorelin include Injection site reactions, Flushing, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
GHK-Cu is a naturally occurring copper-binding peptide found in human plasma that declines with age. It has been extensively studied for skin rejuvenation due to its ability to stimulate collagen and ...
View Full GHK-Cu GuideSermorelin is a bioidentical synthetic version of growth hormone releasing hormone (GHRH) consisting of the first 29 amino acids of the full 44-amino acid GHRH molecule. It was previously FDA-approved...
View Full Sermorelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between GHK-Cu and Sermorelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.